WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹422 Cr | ₹-718 Cr | ₹-1,521 Cr | ₹-762 Cr | ₹-840 Cr |
What is the latest Net Current Assets ratio of WOCKHARDT ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹422 Cr |
| Mar2024 | ₹-718 Cr |
| Mar2023 | ₹-1,521 Cr |
| Mar2022 | ₹-762 Cr |
| Mar2021 | ₹-840 Cr |
How is Net Current Assets of WOCKHARDT Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹422 Cr | Positive | |
| Mar2024 | ₹-718 Cr | Negative | |
| Mar2023 | ₹-1,521 Cr | Negative | |
| Mar2022 | ₹-762 Cr | Negative | |
| Mar2021 | ₹-840 Cr | - | |
Compare Net Current Assets of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹22,854.8 Cr | -3.2% | 5.5% | -1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -3.2% |
5.5% |
-1.8% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses